<DOC>
	<DOCNO>NCT01437670</DOCNO>
	<brief_summary>A prospective , multicenter , observation study estimate dry mouth OAB patient solifenacin</brief_summary>
	<brief_title>Observational Study Estimate Dry Mouth OAB Patients With Solifenacin</brief_title>
	<detailed_description>To estimate dry mouth impact efficacy drug overactive bladder patient solifenacin</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>1 ) male female patient 20 year age old 2 ) clinical history OAB least 3 month prior visit 2 3 ) 3 total score 2 Q 3 index OABSS questionnaire 1 ) In clinical trial , female pregnant , intent become pregnant breastfeed 2 ) postvoided residual urine volume &gt; 150ml 3 ) history catheterization due acute urinary retention 4 ) history pelvic surgery within 6 month 5 ) 6 ) 7 ) history neurovascular disease Parkinson 's disease , cerebral vascular disease , spinal injury multiple sclerosis 8 ) patient indwell catheter intermittent catheterization 9 ) active recurrent ( &gt; 3 episode per year ) urinary tract infection 10 ) use follow medication least 2 week anticholinergic Tricyclic antidepressant , antiepilepsy drug , antiParkinson 's disease drug , antiarrythmia drug type I Chlorpromazine , Thioridazine , Piperazine MAO inhibitor 11 ) Patient currently take take within past 4 week alphablocker treatment benign prostatic hypertrophy 12 ) Patient currently take take within past 8 week 5ARI estrogen medication 13 ) Patient currently use use medication know activity inhibitor inducer cytochrome P4503A4 ( CYP3A4 )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>